Clinical Trial Update: Clinical and Radiographic Evaluation of Chitosan Versus Formocresol After Vital Pulpotomy of Primary Molars [NA]

View source ↗

Summary

A clinical trial evaluating chitosan versus formocresol after vital pulpotomy in primary molars; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Reversible Pulpitis

Drugs mentioned

• Chitosan (Chitosan)
• Formocresol (Formocresol)

Snippet

Sponsor: Cairo University | Conditions: Pulpitis - Reversible, Pulpotomy | NA | Status: NOT_YET_RECRUITING